Valuation: Hofseth BioCare ASA

Market Cap 695M 72.27M 63.78M 60.34M 54.72M 103M 6.93B 104M 724M 279M 3.54B 271M 265M 11.4B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 987M 103M 90.67M 85.79M 77.8M 146M 9.86B 147M 1.03B 397M 5.03B 386M 377M 16.2B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
74.84%
Yield 2024 *
-
Yield 2025 -
1 day-3.27%
1 week-0.75%
Current month-4.32%
1 month-6.99%
3 months-1.12%
6 months-8.28%
Current year+0.76%
1 week 1.14
Extreme 1.145
1.5
1 month 1.14
Extreme 1.145
1.5
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.1
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-31
Director of Finance/CFO - 2026-08-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 2015-04-30
Director/Board Member - -
Director/Board Member - 2021-12-02
Date Insider Type Main position Quantity % Market Cap. Importance
7/14/23 Buy 74,000 0.0187%
2/28/23 Buy

Chief Technology Officer

200,000 0.0506%
2/17/23 Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-3.27%-0.75%-23.12%-53.00% 72.27M
-0.96%-1.08%+5.78%-26.49% 235B
-1.43%-2.88%-5.29%-14.52% 75.71B
-1.24%-3.51%-19.86%+12.44% 42.83B
0.00%+0.86%+82.59%+541.56% 43.18B
-1.22%-3.57%+31.65%+5.28% 38.27B
-1.82%-4.18%-12.33%-19.33% 32.43B
+2.67%+2.26%+20.37%+78.74% 30.14B
-0.47%-2.29%-8.75%-30.29% 27.81B
-1.24%-4.50%+14.48%+18.17% 26.85B
Average -0.65%-1.82%+8.55%+51.25% 55.22B
Weighted average by Cap. -0.71%-1.74%+9.49%+32.93%

Financials

2024 2025
Net sales 266M 27.63M 24.38M 23.07M 20.92M 39.22M 2.65B 39.61M 277M 107M 1.35B 104M 101M 4.36B 256M 26.67M 23.54M 22.27M 20.2M 37.87M 2.56B 38.24M 267M 103M 1.31B 100M 97.97M 4.21B
Net income -125M -13.04M -11.51M -10.89M -9.87M -18.51M -1.25B -18.69M -131M -50.33M -639M -48.95M -47.89M -2.06B -135M -14.03M -12.39M -11.72M -10.63M -19.92M -1.35B -20.12M -141M -54.18M -688M -52.7M -51.55M -2.21B
Net Debt 145M 15.12M 13.34M 12.62M 11.45M 21.46M 1.45B 21.68M 151M 58.36M 741M 56.77M 55.53M 2.38B 293M 30.47M 26.89M 25.45M 23.08M 43.26M 2.92B 43.69M 305M 118M 1.49B 114M 112M 4.81B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
26-09-29 NOK 1.330 -3.27% 323,180
26-09-28 NOK 1.375 -2.48% 301,545
26-09-25 NOK 1.410 +12.35% 1,443,125
26-09-24 NOK 1.255 -0.79% 29,430
26-09-23 NOK 1.265 -5.60% 180,152